In consultation with Consulting Editor, Dr. Lucky Jain, Drs. Jonathan M. Davis and Errol R. Norwitz have put together a state-of the-art issue of the Clinics in Perinatology devoted to Perinatal Pharmacology. Clinical review articles are specifically devoted to the following: Drugs for the prevention and treatment of preterm labor; Drugs for the prevention and treatment of hypertensive disorders of pregnancy; Drugs to promote neuroprotection; Medications that cause fetal anomalies and possible prevention strategies; Safety and efficacy of psychotropic medications during pregnancy; Treatment of viral infections during pregnancy (HIV, herpes, CMV, hepatitis C); Drugs to control diabetes during pregnancy; Cardiotonic drugs; Drugs to treat coagulation disorders in the newborn; Drugs for the prevention and treatment of bronchopulmonary dysplasia; Drugs for the prevention and treatment of neonatal brain injury; Drugs for the prevention and treatment of sepsis in the newborn; Analgesia, opioids and other drug use during pregnancy and Neonatal Abstinence Syndrome; Medications and breast feeding; Principles of pharmacokinetics in the pregnant woman and fetus; and Challenges in designing clinical trials to test new drugs in the pregnant woman and fetus. Readers will come away with the latest information on therapeutics as they seek to utilize evidence-based recommendations to improve patient outcomes.

Along with Consulting Editor, Dr. Lucky Jain, Dr. Goudy has created a current issue that looks at ENT issues with newborns. Expert authors from top institutions have submitted clinical reviews on the following topics: Airway anomalies; Fetal evaluation and airway management; Hearing loss and failed NBHS; Aspiration and dysphagia in the new born; Cleft lip and palate; Microtia and facial anomalies; Cranial synostosis; Pierre Robin sequence; Vascular malformations; Choanal atresia and other nasal masses; Congenital neck masses; Subglottic stenosis; Tracheostomy in the newborn; and Stridor. Readers will come away with the information they need to make informed clinical decisions to improve patient outcomes.

With collaboration of Dr. Lucky Jain, Consulting Editor, Dr. Caplan has assembled articles devoted to the most current clinical advances in necrotizing enterocolitis. He has invited expert authors from top institutions to contribute timely reviews on the following topics: Biomarker Discovery: New markers that improve early diagnostic capability; Probiotics: State of the art; NEC Pathophysiology: How microbiome data alters our understanding; Effect of Human Milk on NEC; Influence of Growth Factors on the Development of NEC; Can Fish Oil Reduce the Incidence of NEC by Altering the Inflammatory Response; Oral Mother’s Milk: State of the art and influence on NEC; Does Surgical Management Alter the Outcome of NEC; Epidemiology of NEC: New considerations and influence of PRBC transfusions and anemia; Role of Abdominal Ultrasound in Diagnosis of NEC; and Modifiable Risk Factors in NEC: 2018. Readers will come away with the scientific and medical information they need to make clinical decisions to improve patient outcomes.

In consultation with Consulting Editor, Dr. Lucky Jain, Drs. Maximo Vento and Waldemar Carlo have put together a state-of the-art issue of the Clinics in Perinatology devoted to Perinatal Pharmacology. Clinical review articles are specifically devoted to the following: Monitoring and assessment of oxygenation in infants; Oxygen toxicity in neonates; New methods for non-invasive oxygen administration; Targeting oxygen in preterm and term infants starting at birth; Newborn resuscitation in settings without access to supplemental oxygen; Noninvasive versus invasive ventilatory support; Nasal SIMV versus Nasal CPAP before and after invasive ventilatory support; Is high-flow cannula inferior to CPAP for neonates?; Intermittent hypoxia: Importance; Closed-loop control of inspired oxygen in neonates: Compliance with targets; Meta-analysis oxygenation saturation targeting trials: Do infant subgroups matter?; Targets of oxygen saturation to optimize eye outcomes; Achieved oxygenation saturations and outcome in extremely preterm infants; Pulmonary hypertension in preterm infants; and Current recommendations and practice of oxygen therapy in preterm infants. Readers will come away with the latest information on oxygen therapy as they seek to utilize evidence-based recommendations to improve patient outcomes.

The need for safe and effective use of medicines in children and WHO's initiative "Make Medicines Child Size" have boosted research and educational activities in the area of pediatric clinical drug research. This issue focuses on both general and specific aspects of neonatal and pediatric clinical pharmacology including ethics, pharmacogenomics, metabolomics, adverse drug reactions, pain medication, pulmonary hypertension and several other hot topics. The editors have been able to find outstanding authors for the different parts on neonatal and pediatric pharmacology.

"Neonatal and Pediatric Pharmacology offers guidelines for safe, effective, and rational drug therapy in newborns, children and adolescents. The book provides relevant and useful data on the molecular, physiologic, biochemical, and pharmacologic mechanisms of drug action and therapy in this population. The authors identify areas of innovative basic and translational research necessary for the continuing evaluation and development of drugs for the fetus, newborns, children and adolescents. Neonatal and Pediatric Pharmacology is is a valuable reference for all health care professionals who treat the fetus, newborns, children, and adolescents, including neonatologists, nurses, pediatricians, general practitioners, students, obstetricians, perinatologists, surgeons and allied health professionals. It will be useful anytime during the day and especially in the middle of the night when knowledge of appropriate indications, safe and effective use, dosage, and therapeutic regimen for a certain drug or molecular entity is immediately needed. The book is also directed to those involved in basic, clinical, and other academic pharmacological research, the pharmaceutical industry, and regulatory agencies dealing with drug and therapeutic developments for this population. Those teaching pharmacology and therapeutics will find this compilation of information extremely useful in preparing teaching materials"--Provided by publisher.

Introducing Diseases, Complications, and Drug Therapy in Obstetrics— A Guide for Clinicians. Edited by Gerald Briggs and Michael Nageotte, two of the leading names in maternal-fetal medicine, this new resource both answers your questions and provides practical tools for your daily patient care. This book is comprised of 27 chapters and broken down in three key sections: I. General Considerations in Pregnancy and Lactation II. Complications Unique to Pregnancy III. Treatment of Chronic Diseases in Pregnancy In sections II and III, case discussions bookend the chapters and there are extensive figures, tables, and discussion questions throughout. This text is designed to help you navigate the best course of treatment for your patients. Learn how to safely treat expectant mothers who suffer from chronic diseases, such as: Asthma Depression Gestational diabetes Epilepsy Chronic hypertension Infectious disease Nausea Autoimmune disease Thromboembolic disease Thyroid disease The two expert editors and thirty-two contributors cover many of the questions your patients may ask, including: - Which over-the-counter medicines are safe? - What physiologic changes are normal during pregnancy? - Will this cause my baby any developmental delays? - Is this medication safe during lactation? If you work with pregnant women and lactating mothers, you need to understand the risks and rewards of drug therapy. Your well-informed choices can save lives.